Literature DB >> 21511858

Patient outcomes are better for unruptured cerebral aneurysms treated at centers that preferentially treat with endovascular coiling: a study of the national inpatient sample 2001-2007.

W Brinjikji1, A A Rabinstein, G Lanzino, D F Kallmes, H J Cloft.   

Abstract

BACKGROUND AND
PURPOSE: Practice patterns vary widely among centers with regard to the treatment of unruptured aneurysms. The purpose of the current study was to correlate outcome data with practice patterns, specifically the proportion of unruptured aneurysms treated with neurosurgical clipping versus endovascular coiling.
MATERIALS AND METHODS: Using the NIS, we evaluated outcomes of patients treated for unruptured aneurysms in the United States from 2001 to 2007. Hospitalizations for clipping or coiling of unruptured cerebral aneurysms were identified by cross-matching ICD codes for diagnosis of unruptured aneurysm with procedure codes for clipping or coiling of cerebral aneurysms. Mortality and morbidity, measured as "discharge to long-term facility," were evaluated in relation to the fraction of cases treated with coils versus clipping as well as the annual number of unruptured aneurysms treated by individual hospitals and individual physicians.
RESULTS: Markedly lower morbidity (P < .0001) and mortality (P = .0015) were noted in centers that coiled a higher percentage of aneurysms compared with the proportion of aneurysms clipped. Multivariate analysis showed that greater annual numbers of aneurysms treated by individual practitioners were significantly related to decreased morbidity (OR = 0.98, P < .0001), while the association between morbidity and the annual number of aneurysms treated by hospitals was not significant (OR = 1.00, P = .89).
CONCLUSIONS: Centers that treated a higher percentage of unruptured aneurysms with coiling compared with clipping achieved markedly lower rates of morbidity and mortality. Our results also confirm that treatment by high-volume practitioners is associated with decreased morbidity.

Entities:  

Mesh:

Year:  2011        PMID: 21511858      PMCID: PMC8013139          DOI: 10.3174/ajnr.A2446

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

1.  Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals.

Authors:  Naomi S Bardach; Shoujun Zhao; Daryl R Gress; Michael T Lawton; S Claiborne Johnston
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

2.  Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes.

Authors:  S C Johnston
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

3.  In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume.

Authors:  Brian L Hoh; James D Rabinov; Johnny C Pryor; Bob S Carter; Fred G Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

4.  Inaccuracy of the administrative database: comparative analysis of two databases for the diagnosis and treatment of intracranial aneurysms.

Authors:  Graeme F Woodworth; Clinton J Baird; Giannina Garces-Ambrossi; James Tonascia; Rafael J Tamargo
Journal:  Neurosurgery       Date:  2009-08       Impact factor: 4.654

5.  In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume.

Authors:  Fred G Barker; Sepideh Amin-Hanjani; William E Butler; Christopher S Ogilvy; Bob S Carter
Journal:  Neurosurgery       Date:  2003-05       Impact factor: 4.654

6.  Use of endovascular coil embolization and surgical clip occlusion for cerebral artery aneurysms.

Authors:  John A Cowan; John Ziewacz; Justin B Dimick; Gilbert R Upchurch; B Gregory Thompson
Journal:  J Neurosurg       Date:  2007-09       Impact factor: 5.115

7.  Relationship between the volume of craniotomies for cerebral aneurysm performed at New York state hospitals and in-hospital mortality.

Authors:  R A Solomon; S A Mayer; J J Tarmey
Journal:  Stroke       Date:  1996-01       Impact factor: 7.914

8.  Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states.

Authors:  DeWitte T Cross; David L Tirschwell; Mary Ann Clark; Dan Tuden; Colin P Derdeyn; Christopher J Moran; Ralph G Dacey
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

Review 9.  Guidelines for the surgical treatment of unruptured intracranial aneurysms: the first annual J. Lawrence pool memorial research symposium--controversies in the management of cerebral aneurysms.

Authors:  Ricardo J Komotar; J Mocco; Robert A Solomon
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

10.  Impact of hospital-related factors on outcome after treatment of cerebral aneurysms.

Authors:  Mitchell F Berman; Robert A Solomon; Stephan A Mayer; S Claiborne Johnston; Pixie P Yung
Journal:  Stroke       Date:  2003-08-07       Impact factor: 7.914

View more
  25 in total

1.  Trends in hospital procedure volumes for intra-arterial treatment of acute ischemic stroke: results from the paul coverdell national acute stroke program.

Authors:  Ganesh Asaithambi; Xin Tong; Kamakshi Lakshminarayan; Sallyann M Coleman King; Mary G George
Journal:  J Neurointerv Surg       Date:  2020-03-13       Impact factor: 5.836

2.  The treatment of unruptured cerebral aneurysms: cause for concern?

Authors:  A J Molyneux
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-28       Impact factor: 3.825

3.  Unruptured intracranial aneurysms: why clinicians should not resort to epidemiologic studies to justify interventions.

Authors:  J Raymond; T E Darsaut; M Kotowski; M W Bojanowski
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-08       Impact factor: 3.825

4.  European recommendations on organisation of interventional care in acute stroke (EROICAS).

Authors:  Jens Fiehler; Christophe Cognard; Mauro Gallitelli; Olav Jansen; Adam Kobayashi; Heinrich P Mattle; Keith W Muir; Mikael Mazighi; Karl Schaller; Peter D Schellinger
Journal:  Eur Stroke J       Date:  2016-07-26

Review 5.  The endonasal approach for treatment of cerebral aneurysms: A critical review of the literature.

Authors:  Daniel M Heiferman; Aravind Somasundaram; Alexis J Alvarado; Adam M Zanation; Amy L Pittman; Anand V Germanwala
Journal:  Clin Neurol Neurosurg       Date:  2015-05-04       Impact factor: 1.876

6.  Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients - a position paper endorsed by ESMINT and ESNR : part II: methodology of future trials.

Authors:  Jens Fiehler; Michael Söderman; Francis Turjman; Philip M White; Søren Jacob Bakke; Salvatore Mangiafico; Rüdiger von Kummer; Mario Muto; Christophe Cognard; Jan Gralla
Journal:  Neuroradiology       Date:  2012-09-05       Impact factor: 2.804

7.  In vivo response to an implanted shape memory polyurethane foam in a porcine aneurysm model.

Authors:  Jennifer N Rodriguez; Fred J Clubb; Thomas S Wilson; Matthew W Miller; Theresa W Fossum; Jonathan Hartman; Egemen Tuzun; Pooja Singhal; Duncan J Maitland
Journal:  J Biomed Mater Res A       Date:  2013-05-23       Impact factor: 4.396

8.  Endovascular embolization of branch-incorporated cerebral aneurysms.

Authors:  Yasuhiro Kawabata; Takuya Nakazawa; Shunichi Fukuda; Satoru Kawarazaki; Tomokazu Aoki; Takumi Morita; Tetsuya Tsukahara
Journal:  Neuroradiol J       Date:  2017-12

9.  Cerebrovascular complications and utilization of endovascular techniques following transsphenoidal resection of pituitary adenomas: a study of the Nationwide Inpatient Sample 2001-2010.

Authors:  Waleed Brinjikji; Giuseppe Lanzino; Harry J Cloft
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

Review 10.  Risk Factors for Growth of Intracranial Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  W Brinjikji; Y-Q Zhu; G Lanzino; H J Cloft; M H Murad; Z Wang; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-26       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.